第一个阶段试验的通用3+3 (G3) 设计:为临床医生设计
Yuan Ji1, Yunxuan Zhang1, Andrew Ji2
1Department of Public Health Sciences, The University of Chicago, IL, United States of America.
Contemporary clinical trials
|September 14, 2025
概括
一般化3+3 (G3) 设计为剂量检测试验提供了一个无软件的方法,性能与现代统计模型相比. 这种简单,透明的方法有助于临床医生在没有专门软件的情况下选择最大耐受剂量 (MTD).
科学领域:
- 临床试验 临床试验
- 生物统计学 生物统计学
- 药理学 药理学是指药理学的学科.
背景情况:
- 传统的剂量检测设计,如3+3被广泛使用,但可能是不灵活的.
- 现代剂量检测设计往往依赖于复杂的统计模型和专门的软件.
- 需要更简单,更容易使用的剂量检测方法,以保持统计学严格.
研究的目的:
- 开发一个简单的,无软件的剂量检测设计.
- 确保新设计的性能与现有的统计模型相比.
- 为了扩大传统的3+3设计的灵活性.
主要方法:
- 一般化3+3 (G3) 设计采用基于参与者数量和剂量限制毒性 (DLT) 事件的算术规则.
- 计算机模拟使用已确定的文献场景进行,包括FDA采用的场景.
- 评估G3设计的性能与3+3设计和现代统计模型进行了对比.
主要成果:
- 对于小队 (3和6名参与者) 的3+3设计,G3设计的结果与3+3设计相同.
- 它显示了与现代统计设计非常相似的结果.
- 与3+3设计相比,G3设计显示了最大耐受剂量 (MTD) 和患者分配的更好选择.
- 最重要的是,G3设计可以手动执行,与软件依赖的现代设计不同.
结论:
- G3设计增强了3+3方法,允许任意数量的参与者进行灵活的决策.
- 它的直接和透明性质,加上不需要专门的软件,使得它对临床医生来说非常实用.
- G3设计特别适合用于以毒性结果为重点的经典剂量确定试验.
相关概念视频
01:11Clinical Trials: Overview
4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
01:16Clinical Trials
10.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.2K
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
183
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
183
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
216
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
216
01:28Dosage Regimens: Designs and Approaches
266
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
266
01:20Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
228
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
228